[{"_id":"556499acfac443afdd393336","決算期":"2014年9月期","証券コード":"4554","会社名":"富士製薬工業(株)【4554】","会計方式":"日本方式","決算発表日":"2014年11月14日","決算月数":"12か月","売上高":"29,215百万円","営業利益":"3,173百万円","経常利益":"3,198百万円","当期利益":"2,078百万円","EPS（一株当たり利益）":"140.53円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,826.63円","総資産":"49,027百万円","自己資本":"28,543百万円","資本金":"3,799百万円","有利子負債":"5,600百万円","自己資本比率":"58.2%","ROA（総資産利益率）":"4.71%","ROE（自己資本利益率）":"7.90%","総資産経常利益率":"7.25%","日付":"2015-05-26T16:05:01.729Z"},{"_id":"556499acfac443afdd393337","決算期":"2013年9月期","証券コード":"4554","会社名":"富士製薬工業(株)【4554】","会計方式":"日本方式","決算発表日":"2013年11月14日","決算月数":"12か月","売上高":"25,174百万円","営業利益":"3,261百万円","経常利益":"3,376百万円","当期利益":"2,068百万円","EPS（一株当たり利益）":"146.48円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,704.46円","総資産":"39,138百万円","自己資本":"24,066百万円","資本金":"2,447百万円","有利子負債":"6,271百万円","自己資本比率":"61.5%","ROA（総資産利益率）":"5.28%","ROE（自己資本利益率）":"8.59%","総資産経常利益率":"8.63%","日付":"2015-05-26T16:05:01.729Z"},{"_id":"556499acfac443afdd393338","決算期":"---","証券コード":"4554","会社名":"富士製薬工業(株)【4554】","会計方式":"---","決算発表日":"---","決算月数":"---","売上高":"---","営業利益":"---","経常利益":"---","当期利益":"---","EPS（一株当たり利益）":"円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"---","総資産":"---","自己資本":"---","資本金":"---","有利子負債":"---","自己資本比率":"---","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","日付":"2015-05-26T16:05:01.729Z"}]